Institut Bergonié: Neoplasms trials
The registry lists 13 Neoplasms studies with Institut Bergonié as lead sponsor. 1 are open to participants now and 10 have results posted.
Phase 1 1Phase 2 4No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- Remote Monitoring for Ambulatory Care of Elderly Patients With CancerCompletedNCT04913259Not applicableResults posted
- Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer Trials (SURROGATE-ICI)CompletedNCT03963518Results posted
- Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer OriginTerminatedNCT03960021Not applicableResults posted
- Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)CompletedNCT03694171Results posted
- Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older AdultsCompletedNCT03676218Results posted
- Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)Active, not recruitingNCT03676010Results posted
- CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in OncologyCompletedNCT03302767Not applicableResults posted
- French Validation of an Interview Guide to Cancer Announcement : the Psycho Oncology Basic DocumentationCompletedNCT02874001Results posted
- Predicting Severe Toxicity of Targeted Therapies in Elderly Patients With CancerCompletedNCT02751827Results posted
- Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic SurgeryCompletedNCT00210132Phase 2Results posted
- Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyCompletedNCT04095208Phase 2
- Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid TumorsActive, not recruitingNCT03915678Phase 2